Zobrazeno 1 - 10
of 340
pro vyhledávání: '"Alex C, Spyropoulos"'
Publikováno v:
Vascular Investigation and Therapy, Vol 7, Iss 3, Pp 47-53 (2024)
The annual incidence of symptomatic deep venous thrombosis (DVT) and venous thromboembolic (VTE) (DVT plus pulmonary embolism) in the adult population is estimated to be 50–100 and 75–150/100,000, respectively, and the incidence doubles for every
Externí odkaz:
https://doaj.org/article/7f6b1486dd0c408bb3101af7811c1dcf
Autor:
Marc Cohen, MD, Alex C. Spyropoulos, MD, Shaun G. Goodman, MD, Sarah A. Spinler, PharmD, Marc P. Bonaca, MD, Theresa M. Redling, DO, Gautam Visveswaran, MD, Sumit Sohal, MD, MS
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 8, Iss 4, Pp 321-328 (2024)
Externí odkaz:
https://doaj.org/article/40b70e343e16486a952fdb481ac67d30
Autor:
Mark Goldin, Kolton Smith, Ioannis Koulas, Tungming Leung, Mayuri Ravi, Sanjit Parhar, Sejal Shah, Kayla Floyd, Lori Ohanesian, Rachel Bain, Daniella Defonte, Kanta Ochani, Amanda Lin, Bhumi Patel, Nikolaos Tsaftaridis, Jack Jnani, Alex C. Spyropoulos
Publikováno v:
TH Open, Vol 08, Iss 02, Pp e209-e215 (2024)
Background Andexanet is U.S. Food and Drug Administration (FDA) approved for the reversal of critical bleeding from factor Xa inhibitors and off-label for surgical reversal. Data are lacking on andexanet administration processes.
Externí odkaz:
https://doaj.org/article/b4c8d7cd0de345d594f879f98c252755
Autor:
Sahrish Shah, MBBS, Meritxell Urtecho, MD, Mohammed Firwana, MBBS, Tarek Nayfeh, MD, Bashar Hasan, MD, Ahmad Nanaa, MD, Samer Saadi, MD, David N. Flynn, MD, MBA, Rami Abd-Rabu, MBBS, Mohamed O. Seisa, MD, Noora S. Rajjoub, Leslie C. Hassett, ML, Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC, James D. Douketis, MD, FCCP, M. Hassan Murad, MD, MPH
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 6, Pp 564-573 (2022)
Objective: To summarize the available evidence about the perioperative management of patients who are receiving long-term antiplatelet therapy and require elective surgery/procedures. Methods: This systematic review supports the development of the Am
Externí odkaz:
https://doaj.org/article/007c67d539574fa4a96dbc954e4ac21a
Autor:
Caroline Cândida Carvalho de Oliveira, Leandro Barile Agati, Camilla Moreira Ribeiro, Valéria Cristina Resende Aguiar, Roberto Augusto Caffaro, Marisa da Silva Santos, Ricardo Ribeiro Alves Fernandes, Carlos Alberto da Silva Magliano, Alfonso Tafur, Alex C. Spyropoulos, Renato Delascio Lopes, Jawed Fareed, Eduardo Ramacciotti
Publikováno v:
The Lancet Regional Health. Americas, Vol 24, Iss , Pp 100543- (2023)
Summary: Background: In patients at high risk of thromboembolism who were discharged after hospitalisation due to COVID-19, thromboprophylaxis with rivaroxaban 10 mg/day for 35 days significantly improved clinical outcomes, reducing thrombotic events
Externí odkaz:
https://doaj.org/article/768a042117c64291b54a65ce345eea99
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
The Management of Anticoagulation in the Periprocedural Period (MAPPP) app is a free tool providing up-to-date guidelines on the periprocedural management of patients on long-term anticoagulants. After validating its effectiveness in the post-procedu
Externí odkaz:
https://doaj.org/article/50f8f399228c4bc5bf3ce2f1047324f3
Autor:
Alex C. Spyropoulos, Gary E. Raskob, Theodore E. Spiro, Wentao Lu, Yoriko De Sanctis, John Albanese, Alexandre Mebazaa, Elliot S. Barnathan
Publikováno v:
TH Open, Vol 06, Iss 04, Pp e304-e308 (2022)
This post hoc subgroup analysis examined efficacy and safety outcomes with extended thromboprophylaxis rivaroxaban compared with in-hospital enoxaparin in 2,078 patients from the MAGELLAN study who had a hospitalization for heart failure or a history
Externí odkaz:
https://doaj.org/article/c30a282dfc12451e8dc11369d84e91b0
Autor:
Gary E. Raskob, Walter Ageno, Gregory Albers, C. Gregory Elliott, Jonathan Halperin, Gregory Maynard, Philippe Gabriel Steg, Jeffrey I. Weitz, John Albanese, Zhong Yuan, Bennett Levitan, Wentao Lu, Eun Young Suh, Theodore Spiro, Concetta Lipardi, Elliot S. Barnathan, Alex C. Spyropoulos
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 20 (2022)
Background Venous thromboembolism (VTE) often occurs after hospitalization in medically ill patients, but the population benefit–risk of extended thromboprophylaxis remains uncertain. Methods and Results The MARINER (Medically Ill Patient Assessmen
Externí odkaz:
https://doaj.org/article/3f35590df43c41208e8ddc289edabcaa
Autor:
Alex C. Spyropoulos, James M. Crawford, Yen-Wen Cindy Chen, Veronica Ashton, Alicia K. Campbell, Dejan Milentijevic, W. Frank Peacock
Publikováno v:
TH Open, Vol 06, Iss 04, Pp e408-e420 (2022)
Abstract Background Most symptoms of coronavirus 2019 (COVID-19) are mild; however, some patients experience cardiovascular complications, including thromboembolic events and death. Data are needed to better inform prevention and treatment of these
Externí odkaz:
https://doaj.org/article/04918bee1c43480b9a82143a8f0c838c
Autor:
W. Frank Peacock MD, FACEP, FACC, FESC, James M. Crawford MD, PhD, Yen-Wen (Cindy) Chen PhD, Veronica Ashton MPH, Alicia K. Campbell PharmD, Dejan Milentijevic PhD, MBA, Alex C. Spyropoulos MD, FACP, FCCP, FRCPC
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Limited data are available on thromboembolic events (TEEs) and mortality in outpatients with coronavirus disease 2019 (COVID-19). This retrospective, observational cohort study identified non-hospitalized COVID-19 outpatients (01/21/2020-01/07/2021)
Externí odkaz:
https://doaj.org/article/e763408b7d534e61adeac7384af2b8bb